CancerConsultants.com Announces Recent Updates to the Renal Cancer Information Center

As of April 23, 2008 CancerConsultants.com has completed our most recent updates to our Renal Cancer Information Center, adding the latest findings in prevention, screening, treatment, and cancer management to our comprehensive, in-depth kidney cancer content.

As part of Cancer Consultants’ ongoing mission to provide interested individuals, cancer patients, and their families and caregivers with access to the most current information about the prevention, screening, treatment, and overall management of cancer, we regularly update our content with recent, ground-breaking findings in all aspects of cancer prevention and care. Our almost thirty unique Cancer Information Centers cover a broad range of cancer types and subtypes, each providing readers with up-to-date disease overviews as well as the latest information on screening, prevention, and treatment. Each information center also features links to late-breaking news, tips for patients, newsletter subscriptions, clinical trials information, online communities, and more.

Featured Renal Cancer Information Center Update:

Updates to the Renal Cancer Information Center discuss the importance of newer targeted therapies such as Nexavar® (sorafenib), Sutent® (sunitinib), and Torisel® (temsirolimus); the role of immunotherapy drugs such as Proleukin® (aldesleukin); and strategies to improve the systemic and surgical treatment of kidney cancer.

For more of the latest information on renal cancer, visit the Renal Cancer Information Center

As of April 23, 2008 CancerConsultants.com has completed our most recent updates to our Renal Cancer Information Center, adding the latest findings in prevention, screening, treatment, and cancer management to our comprehensive, in-depth kidney cancer content.

As part of Cancer Consultants’ ongoing mission to provide interested individuals, cancer patients, and their families and caregivers with access to the most current information about the prevention, screening, treatment, and overall management of cancer, we regularly update our content with recent, ground-breaking findings in all aspects of cancer prevention and care. Our almost thirty unique Cancer Information Centers cover a broad range of cancer types and subtypes, each providing readers with up-to-date disease overviews as well as the latest information on screening, prevention, and treatment. Each information center also features links to late-breaking news, tips for patients, newsletter subscriptions, clinical trials information, online communities, and more.

Featured Renal Cancer Information Center Update:

Updates to the Renal Cancer Information Center discuss the importance of newer targeted therapies such as Nexavar® (sorafenib), Sutent® (sunitinib), and Torisel® (temsirolimus); the role of immunotherapy drugs such as Proleukin® (aldesleukin); and strategies to improve the systemic and surgical treatment of kidney cancer.

For more of the latest information on renal cancer, visit the Renal Cancer Information Center.

Share


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS